Manufacturers Life Insurance Company, The Theravance Biopharma, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 15,432 shares of TBPH stock, worth $143,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,432
Previous 15,611
1.15%
Holding current value
$143,671
Previous $125,000
16.0%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding TBPH
# of Institutions
127Shares Held
46.3MCall Options Held
600Put Options Held
300-
Madison Avenue Partners, LP New York, NY9.51MShares$88.5 Million14.29% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$69.4 Million2.02% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$44.3 Million9.1% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$35.2 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$25.7 Million2.79% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $622M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...